Doctor profile · Federal record
Dr. Suresh Mukkamala, M.D
Hematology & Oncology Physician (CMS: Hematology/Oncology) · Tucson, AZ
- NPI 1770973398
- Accepts Medicare
- MIPS 95.5 / 100 · 2023
- 23 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
2070 W Rudasill RD Ste 130
Tucson, AZ 857047891
(520) 420-2520
fax (520) 420-2522 - Mailing address
-
Po Box 910221
Dallas, TX 753910221
Credentials & registration
- NPI registered
- February 2015 — 11 yrs on file
- Profile last updated
- May 22, 2025
- Year of graduation
- 2003 — 23 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- Arizona #63423
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1770973398. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
70,211
Distinct HCPCS
10
Medicare allowed
$1,456,022
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
Q5101 |
Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram | 20,040 | 17 | $0 | |
Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 12,615 | 134 | $0 | |
J9144 |
Injection, daratumumab, 10 mg and hyaluronidase-fihj | 9,360 | 15 | $48 | |
J9271 |
Injection, pembrolizumab, 1 mg | 7,580 | 16 | $53 | |
J0185 |
Injection, aprepitant, 1 mg | 4,940 | 17 | $2 | |
J0897 |
Injection, denosumab, 1 mg | 4,320 | 42 | $23 | |
J1568 |
Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | 2,500 | 18 | $42 | |
J1437 |
Injection, ferric derisomaltose, 10 mg | 2,100 | 19 | $20 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 1,282 | 39 | $0 | |
J1626 |
Injection, granisetron hydrochloride, 100 mcg | 1,110 | 38 | $0 |
In context: peer comparison
Among 21 peers in this city , average services per provider: 951. This provider delivers 74× the peer median.Open Payments
Industry payments received
All-time total
$395
Transactions
17
Manufacturers
14
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | 2 | $63.34 | |
| AstraZeneca Pharmaceuticals LP | 2 | $50.98 | |
| Celgene Corporation | 2 | $40.49 | |
| Genmab U.S., Inc. | 1 | $31.14 | |
| SpringWorks Therapeutics, Inc. | 1 | $25.01 | |
| BeiGene USA, Inc. | 1 | $23.94 | |
| Merck Sharp & Dohme LLC | 1 | $23.50 | |
| Gilead Sciences, Inc. | 1 | $22.71 | |
| Daiichi Sankyo Inc. | 1 | $22.47 | |
| Sumitomo Pharma America, Inc. | 1 | $21.93 | |
| SOBI, INC | 1 | $18.46 | |
| PFIZER INC. | 1 | $18.28 | |
| ARRAY BIOPHARMA INC | 1 | $16.38 | |
| Ipsen Biopharmaceuticals, Inc | 1 | $16.23 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
632
Patients
151
Total drug cost
$78,756
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Anastrozole | Generic | 144 | 47 | $3,989 |
| Ondansetron Hcl | Generic | 73 | 36 | $978 |
| Dexamethasone | Generic | 60 | 21 | $865 |
| Gabapentin | Generic | 46 | 0 | $870 |
| Oxycodone Hcl | Generic | 41 | 20 | $413 |
| Prednisone | Generic | 35 | 0 | $147 |
| Trazodone Hcl | Generic | 34 | 0 | $148 |
| Folic Acid | Generic | 33 | 0 | $90 |
| Potassium Chloride | Generic | 31 | 12 | $221 |
| Olanzapine | Generic | 29 | 15 | $226 |
Hospital affiliations
Frequently asked questions
What is Dr. Suresh Mukkamala's medical specialty?
Dr. Suresh Mukkamala practices Hematology & Oncology Physician in Tucson, AZ.
Where does Dr. Suresh Mukkamala practice?
Dr. Suresh Mukkamala practices at 2070 W Rudasill RD Ste 130, Tucson, AZ 857047891. Office phone: 5204202520.
What is Dr. Suresh Mukkamala's NPI?
Dr. Suresh Mukkamala's National Provider Identifier (NPI) is 1770973398, issued by NPPES.
Does Dr. Suresh Mukkamala accept Medicare assignment?
Yes. Dr. Suresh Mukkamala accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Suresh Mukkamala commonly perform?
Top Medicare-reported procedures in 2023: Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS Q5101); Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS Q9967); Injection, daratumumab, 10 mg and hyaluronidase-fihj (HCPCS J9144). Source: CMS Medicare Physician & Other Practitioners file.